From Table F in S1 File, TOP1MT, TOP2A and TOP3A were found to be correlated to significantly worse OS in all stage I NSCLC patients while the expression of TOP1 and TOP2B indicated significantly better OS in stage I, II and II NSCLC patients respectively. This evidence concerns the gene TOP1MT and non-small cell lung carcinoma.